Skip to main content

Zoetis Inc.

corporate_fare Company Profile

Zoetis Inc.

ZTS·NYSE·Life Sciences·CIK 0001555280

Zoetis Inc. is a global animal health company that discovers, develops, manufactures, and sells medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions. The company operates a diversified business, offering products for eight core species: dogs, cats, and horses (companion animals), and cattle, swine, poultry, fish, and sheep (livestock). Its products fall into seven major categories: parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceuticals, and animal health diagnostics. Zoetis has a history spanning nearly 75 years, supporting veterinarians, pet owners, and livestock producers globally. The company was incorporated in Delaware in July 2012, having previously operated as a business unit of Pfizer Inc. Its principal executive offices are located at 10 Sylvan Way, Parsippany, New Jersey 07054. The animal health market is segmented by regional customer needs, which vary due to economic, cultural, epidemiological, treatment, environmental, and regulatory factors.

Zoetis Inc. (NYSE:ZTS) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 17 items for ZTS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 17 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for ZTS spans 10-Q, 8-K, DEF 14A, 10-K.

Recent high-impact activity:

  • Zoetis Beats Q3 Estimates and Raises Guidance, Yet Shares Slide 6% on Pet-Spending Caution
  • Zoetis Q3 10-Q: Revenue Down 1%, Net Income Down 18% to $591M
  • Zoetis Q3 Revenue Slips 1% as U.S. Pet Sales Fall 8%, but Raises Full-Year Adjusted EPS Outlook
  • FDA Grants Emergency Use Authorization for Zoetis' Simparica Trio Against New World Screwworm
  • Zoetis Q2 2026: Flat Revenue as U.S. Companion Animal Weakness Meets Restructuring and Legal Headwinds

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$9.47B
Net Income
$2.67B
Diluted EPS
$6.02
Op. Cash Flow
$2.9B
Free Cash Flow
$2.28B
Gross Profit
$6.8B
Cash & Equivalents
$2.31B
Total Debt
$9.04B
Debt / Equity
2.71×
Net Margin
28.2%
Shares Outstanding
424.93M sh
Source: 10-K · filed 2026-02-12 · accession 0001555280-26-000011

Short Interest & Short Volume

4.78 days to cover

FINRA reported short interest of 16,722,420 shares in ZTS as of the October 30, 2026 settlement, a 4.5% decrease from the prior period — about 4.8 days to cover at its recent average daily volume. On November 20, 2026, 25.9% of ZTS volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)16,722,420 shares as of October 30, 2026
Change vs prior period▼ 4.5%
Days to cover4.78 at avg daily volume of 3,501,427
Daily short volume (FINRA facilities)25.9% of 2,291,348 shares on November 20, 2026
5-day average short volume36.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with Z →
$78.16 -1.20% today
52-week range · as of 2026-11-05 $68.77 – $132.49
Market cap
$32.14B
Volume
6.1M (1.3× avg)
3-mo avg 4.5M
Live data · 2026-11-21 07:27 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ZTS - Latest Insights

ZTS
Nov 05, 2026, 1:15 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $83.15
Real-time Price: $78.16 info
Change: -$4.98 (-6%) info
Market Cap: $32.144B info
ZTS
Nov 05, 2026, 11:40 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $83.48
Real-time Price: $78.16 info
Change: -$5.31 (-6%) info
Market Cap: $32.144B info
ZTS
Nov 05, 2026, 7:00 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $88.78
Real-time Price: $78.16 info
Change: -$10.62 (-12%) info
Market Cap: $32.144B info
ZTS
Aug 13, 2026, 3:51 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $75.45
Real-time Price: $78.16 info
Change: +$2.71 (+4%) info
Market Cap: $32.144B info
ZTS
Aug 06, 2026, 2:32 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $77.03
Real-time Price: $78.16 info
Change: +$1.13 (+1%) info
Market Cap: $32.144B info
ZTS
Aug 06, 2026, 2:10 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $76.28
Real-time Price: $78.16 info
Change: +$1.88 (+2%) info
Market Cap: $32.144B info
ZTS
Aug 06, 2026, 7:19 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $72.00
Real-time Price: $78.16 info
Change: +$6.16 (+9%) info
Market Cap: $32.144B info
ZTS
Aug 06, 2026, 7:06 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $77.00
Real-time Price: $78.16 info
Change: +$1.16 (+2%) info
Market Cap: $32.144B info
ZTS
Jul 17, 2026, 6:15 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $75.31
Real-time Price: $78.16 info
Change: +$2.85 (+4%) info
Market Cap: $32.144B info
ZTS
Jul 14, 2026, 9:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $75.13
Real-time Price: $78.16 info
Change: +$3.03 (+4%) info
Market Cap: $32.144B info
ZTS
Jun 11, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $81.19
Real-time Price: $78.16 info
Change: -$3.03 (-4%) info
Market Cap: $32.144B info
ZTS
May 07, 2026, 4:26 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $87.62
Real-time Price: $78.16 info
Change: -$9.46 (-11%) info
Market Cap: $32.144B info
ZTS
May 07, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $101.50
Real-time Price: $78.16 info
Change: -$23.34 (-23%) info
Market Cap: $32.144B info
ZTS
May 07, 2026, 7:04 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $103.00
Real-time Price: $78.16 info
Change: -$24.84 (-24%) info
Market Cap: $32.144B info
ZTS
Apr 08, 2026, 9:01 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $119.50
Real-time Price: $78.16 info
Change: -$41.34 (-35%) info
Market Cap: $32.144B info
ZTS
Feb 12, 2026, 4:49 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $126.33
Real-time Price: $78.16 info
Change: -$48.17 (-38%) info
Market Cap: $32.144B info
ZTS
Feb 12, 2026, 7:04 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $136.73
Real-time Price: $78.16 info
Change: -$58.57 (-43%) info
Market Cap: $32.144B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets